Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial

Weiping Jia, Xinhua Xiao, Qiuhe Ji, Kyu Jeung Ahn, Lee‐Ming Chuang, Yuqian Bao, Can Pang, Lei Chen, Fei Gao, Yinfang Tu,

The Lancet Diabetes & Endocrinology · 2015 · 41 citations · 28 references

Concepts

References

28